Stock Analysts’ Upgrades for December 27th (ALNY, BVN, CBOE, CBZ, CMCSA, ORMP, PKE, TAC, TBI, TUSK)

Posted by on Dec 27th, 2024

Stock Analysts’ upgrades for Friday, December 27th:

Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Compañía de Minas Buenaventura S.A.A. (NYSE:BVN) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Cboe Global Markets (NASDAQ:CBOE) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

CBIZ (NYSE:CBZ) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Comcast (NASDAQ:CMCSA) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Oramed Pharmaceuticals (NASDAQ:ORMP) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Park Aerospace (NYSE:PKE) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

TransAlta (NYSE:TAC) (TSE:TA) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

TrueBlue (NYSE:TBI) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Mammoth Energy Services (NASDAQ:TUSK) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Titan International (NYSE:TWI) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Receive News & Ratings for Alnylam Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alnylam Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.